Paige Digital Diagnostics

Paige Prostate (FDA and CE-IVD) and Breast (CE-IVD) Digital Diagnostics are delivered through the FDA-cleared & CE-marked FullFocusTM viewer provides pathologists with AI-powered workflows to increase throughput and turnaround time, with greater confidence and accuracy.

Paige Platform

A comprehensive enterprise imaging solution that is inclusive of  viewer, storage capabilities, and digital diagnostics  and is compatible with existing digital pathology solutions, including most scanners, monitors, and laboratory information systems.

Anywhere, Anytime Access with Full Focus™

FullFocus is an intuitive, responsive, FDA-cleared, CE-marked viewer for primary diagnosis. FullFocus is designed for pathologists to further leverage computational pathology products as they become available for clinical use.

Benefits

  • pathologist-centric user experience.
  • Fast performance to load and view digital slides.
  • Access to digital slides for multiple users from any internet-enabled location.*
  • Ready to deliver computational pathology products.
  • Secure, scalable, and highly available storage.
  • Cost-effective and with no upfront capital expenses.
  • Fast to deploy and minimal ongoing maintenance needs.
  • Designed for interoperability with most scanners, monitors, and LIS

​*Per CMS guidelines, remote review is possible during the COVID 19 Public Health Emergency

Digital Diagnostics

Paige offers two  diagnostic tools for Breast Cancer (CE-IVD) and Prostate Cancer Detection (FDA and CE-IVD) that aim to provide pathologists with AI-powered workflows to increase the number of cases that can be reviewed in the same time, with greater confidence and accuracy.

Digital Diagnostic

Paige Prostate Clinical (FDA & CE-IVD)

A prostate cancer solution that detects, grades and quantifies areas suspicious for cancer.

Digital Diagnostic

Paige Breast Clinical (CE-IVD)

A breast cancer solution that detects areas suspicious for cancer.

Solution Type

AI Suite/Add-on

Deployment Environment

Clinical Diagnostics

Regulatory Clearance

Breast Cancer – CE-IVD, Prostate Cancer – CE-IVD, Prostate Cancer – FDA Cleared

Target

Breast Cancer, Prostate Cancer

Platform Dependency

Requires Specific Platform

Deployment Options

Cloud-Based (SaaS)

Reviews

There are no reviews yet.

Be the first to review “Paige Digital Diagnostics”

Your email address will not be published. Required fields are marked *

18 + 10 =

More Solutions from Paige

  • Paige Breast

  • Paige Prostate

  • PAIGE DIGITAL PATHOLOGY VIEWER

Get Pathology News Delivered to Your Inbox

Learn More

PaigeTempus Logo

Paige News

Paige Solutions